Inflammatory changes, recovery and recurrence at COPD exacerbation

European Respiratory Journal

Volumn 29, Issue 3, 2007, Pages 527-534

  Perera, W R ^a   Hurst, J R ^a   Wilkinson, T M A ^a   Sapsford, R J ^a   Mullerova H ^b   Donaldson, G C ^a   Wedzicha, J A ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Exacerbation; Inflammation

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY TRACT INFLAMMATION; SPUTUM LEVEL;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; AGED; ALBUTEROL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; LONDON; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; SPUTUM;

EID: 33847711510     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00092506     Document Type: Article

References (31)

1. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation of quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
2. Donaldson GC, Wilkinson TM, Hurst JR, Perera WR, Wedzicha JA. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 446-452.
3. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 358-364.
4. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-852.
5. Bhowmik A, Seemungal TAR, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55: 114-120.
6. Wedzicha JA, Seemungal TA, MacCallum PK, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000; 84: 210-215.
7. 4. Eur Respir J 2000; 15: 274-280.
8. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001; 17: 1112-1119.
9. Drost EM, Skwarski KM, Sauleda J, et al. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 2005; 60: 293-300.
10. Hurst JR, Perera WR, Wilkinson TMA, Donaldson GC, Wedzicha JA. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 71-78.
11. Wilkinson TMA, Hurst JR, Perera WR, et al. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006; 129: 317-324.
12. Seemungal TAR, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618-1623.
13. Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries JD, Wedzicha JA. Time course and.recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1608-1613.
14. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-105.
15. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931.
16. Roberts CM, Lowe D, Bucknell CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators~ of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002; 57: 137-141.
17. Chu CM, Chan VL, Lin AWN, Wong WY, Leung WS, Lai CKW. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 2004; 59: 1020-1025.
18. Jones PW, Quirk PH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
19. Bhowmik A, Seemungal TAR, Sapsford RJ, Devalia. JL, Wedzicha JA. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998; 53: 953-956.
20. Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 1298-1303.
21. Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationships between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759-764.
22. 1-antiftypsin deficiency and factors associated with decline. Am J Respir Crit Care Med 2001; 164: 1805-1809.
23. Donaldson GC, Seemungal TAR, Patel IS, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995-2004.
24. Hospital Episode Statistics, UK Department of Heath, 2003. www.dh.gov.uk/ PublicationsAndStatistics/Statistics/HospitalEpisodeStatistics/fs/en. Date last accessed: June 7, 2005.
25. Sethi S, File TM. Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem. Curr Med Res Opin 2004; 20: 1511-1521.
26. Sethi S, Evans N, Grant Bj, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Eng J Med 2002; 347: 465-471.
27. Hurst JR, Donaldson GC, Wilkinson TMA, Perera WR, Wedzicha JA. Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J 2005; 26: 846-852.
28. Yamamto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997; 112: 505-510.
29. 1-antitypsin deficiency. Eur Respir J 2000; 15: 886-890.
30. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubert A. Airway inflammation and bronchial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999; 14: 1015-1022.
31. Hill AT, Campbell EJ, Hill SL, Crooks S, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000; 109: 288-295.